← Leaderboards
Michel Baudry
Neuraegis, Inc.
$353,299
Attributed
$706,597
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $489.3K · FY2023–24$500K$375K$250K$125K$0
'23
'24
Funding mix
By agency
NIH$706,597 · 1
By mechanism
R41$706,597 · 1
Top collaborators
- Xiaoning Bi3 shared
Others in their field
Other Rising Stars on “Electroencephalography”
- John Alam · Eip Pharma, Inc.$10,536,018
- Henry Sachs · Emma Pendleton Bradley Hospital$7,940,991
- Ludovica Labruna · Magnetic Tides, Inc.$4,207,384
- Marco Capogrosso · University Of Pittsburgh At Pittsburgh$3,027,117
- Glenn Short III · Atai Therapeutics, Inc.$2,923,842
- Douglas H Kelley · University Of Rochester$2,835,227
Research focus
ElectroencephalographyExcitatory NeuronConditional KnockoutDrug ResistanceEpilepsyEventC57bl/6 MouseCalpain InhibitorDesignDoseAppearanceEncephalitisAnimalsEpileptogenesisBiotechnologyAcuteCalpainCalciumConditioned FearBrainBrain ConcussionAntiepileptogenicBrain InjuriesExhibits
Grant awards (3)
Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy$197,842
R41 · FY2024 · NS · contact PI
Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy$19,487
R41 · FY2024 · NS · contact PI
Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy$489,268
R41 · FY2023 · NS · contact PI